Toronto, Canada
MIMOSA Diagnostics is a Canada-based startup that is dedicated to "Making the invisible, visible." Founded in 2016, MIMOSA offers a proactive approach to skin health, empowering clinicians to intervene earlier or even prevent the need for interventions altogether. The company's products play a crucial role in promoting inclusive and equitable healthcare, enabling patients in remote areas and racialized individuals globally to access the critical healthcare they deserve.
The latest investment in MIMOSA Diagnostics amounted to $10.70M, in the form of a grant received on 14 June 2024. This significant boost was provided by the Government of Canada and INOVAIT, showcasing confidence and support from both public and private sectors in the company's vision and potential.
With its focus on advancing skin health and expanding access to healthcare, MIMOSA Diagnostics has carved a niche for itself in the Health Care and Mobile industries, demonstrating its commitment to innovation and positive social impact.
